Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone morphogenetic protein-2 stimulates Runx2 acetylation.

Eun-Joo Jeon1, Kwang-Youl Lee, Nam-Sook Choi

  • 1Department of Biochemistry, School of Medicine, and Institute for Tumor Research, Chungbuk National University, Cheongju 361-763, Korea.

The Journal of Biological Chemistry
|April 15, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Core binding factor β preserves early chondrogenic identity and prevents hypertrophic transition in cartilage organoids formation.

Cell & bioscience·2026
Same author

Obesity history exacerbates liver macrophage-mediated fibrosis via IGFBP7.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

4-Hexylresorcinol Attenuates Ethanol-Induced Hepatic and Pancreatic Injury by Modulating Metabolic Dysfunction and Endoplasmic Reticulum Stress.

Biomedicines·2026
Same author

Mechanism by which a linoleic acid metabolite suppresses cancer cell growth by inhibiting mTOR.

Cell chemical biology·2026
Same author

RUNX2 enhances vascular remodeling to promote endothelial proliferation in acute liver injury.

International journal of biological sciences·2026
Same author

Spatially resolved osteoblast-traced transcriptomics uncovers TGF-β as a combination target with sclerostin in osteoporosis.

Bone research·2026

Runx2 protein levels, crucial for bone formation, are regulated by acetylation and deacetylation. Inhibiting HDACs boosts Runx2 acetylation, enhancing bone development and osteoblast differentiation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Runx2 (Runt-related transcription factor 2) is a master regulator of osteogenesis, essential for bone-specific gene expression.
  • Runx2 activity is tightly controlled by post-translational modifications and signaling pathways, including the bone morphogenetic protein (BMP) pathway.

Purpose of the Study:

  • To elucidate the molecular mechanisms linking Smurf, histone deacetylases (HDACs), and Runx2 within BMP signaling.
  • To investigate how acetylation and deacetylation influence Runx2 stability and osteoblast differentiation.

Main Methods:

  • Investigated the interplay between BMP-2 signaling, p300-mediated acetylation, HDAC4/5-mediated deacetylation, and Smurf1-mediated ubiquitination of Runx2.
  • Assessed the impact of HDAC inhibition on Runx2 acetylation levels, osteoblast differentiation, and bone formation in response to BMP-2 stimulation.

Related Experiment Videos

Main Results:

  • BMP-2 signaling promotes Runx2 acetylation by p300, enhancing its activity and preventing Smurf1-mediated degradation.
  • HDAC4 and HDAC5 deacetylate Runx2, marking it for Smurf-mediated degradation.
  • Inhibition of HDAC activity leads to increased Runx2 acetylation, potentiating BMP-2-induced osteoblast differentiation and bone formation.

Conclusions:

  • Runx2 protein levels are regulated by a dynamic balance of acetylation, deacetylation, and ubiquitination.
  • Targeting the acetylation status of Runx2 offers a potential therapeutic strategy for bone diseases by modulating osteoblast differentiation and bone formation.